Clinical and Autoimmune Profile of Scleroderma Patients from Western India
Open Access
- 19 October 2014
- journal article
- research article
- Published by Wiley in International Journal of Rheumatology
- Vol. 2014, 1-6
Abstract
Background. Systemic sclerosis (SSc, scleroderma) is a disorder characterized by fibrosis of skin and visceral organs. Pathogenesis of scleroderma is complex and is incompletely understood as yet. Autoantibodies in SSc represent a serologic hallmark which have clinical relevance, with diagnostic and prognostic potential.Objectives. To study distribution of clinical manifestations and to identify frequency of autoantibodies among subtypes of scleroderma patients from Western India.Methodology. One hundred and ten scleroderma patients were clinically classified according to the American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) criteria. All these patients were in active stage of disease. Clinical manifestations were recorded at the time of presentation. Autoantibodies were tested in them by indirect immunofluorescence test and ELISA. Immunoglobulin levels were estimated by nephelometer. These parameters were further correlated with clinical presentation of the disease.Results. Scleroderma patients had M : F ratio of 1 : 10 where mean age at evaluation wasyears and a mean disease duration wasmonths. Clinical subtypes showed that 45 patients (40.9%) had diffused cutaneous (dcSSc) lesions, 32 patients (29.1%) had limited cutaneous (lcSSc) lesions, and 33 patients (30%) had other autoimmune overlaps. The overall frequency of ANA in SSc patients studied was 85.5%. The frequency of anti-Scl70, anti-centromere, anti-endothelial cell antibodies (AECA), and anti-keratinocyte antibodies (AKA) was 62.7%, 22.7%, 30%, and 40.9%, respectively. Anti-Scl70 antibodies were significantly high (75.6% versus 46.9%) among dcSSc patients () whereas anti-centromere antibodies were significantly high (9% versus 38%) among lcSSc patients when these two subtypes were compared ().Conclusion. This study supports that there are geoepidemiological variations among scleroderma patients for their clinical presentation, autoantibody profile, and immune parameters across the country.
Keywords
Funding Information
- Institut National de la Santé et de la Recherche Médicale
This publication has 20 references indexed in Scilit:
- A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosisArthritis & Rheumatism, 2012
- Fluctuation of Anti-Endothelial Cell Antibody Titers in Mixed Connective Tissue Disease2012
- Anti-centromere Antibody-positive Subjects Presenting with Hypertensive Emergency and Renal Dysfunction in the Absence of Skin Manifestations: A Variant of Systemic Sclerosis or a Novel Entity?Internal Medicine, 2012
- Autoanticorpos em esclerodermia e sua associação ao perfil clínico da doença: estudo em 66 pacientes do sul do BrasilAnais Brasileiros de Dermatologia, 2011
- Validation of potential classification criteria for systemic sclerosisArthritis Care & Research, 2011
- Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical featuresArthritis Research & Therapy, 2011
- Autoantibody profile and clinical correlation in a group of patients with systemic sclerosis in southern Brazil.2011
- Gastrointestinal involvement in patients with systemic sclerosisPolish Archives of Internal Medicine, 2010
- A proposal of criteria for the classification of systemic sclerosis.2004
- Progressive systemic sclerosis in south India.1991